ArticleEvidence-based medicine2014

Omalizumab decreases exacerbations and allows a step down in daily inhaled corticosteroid dose in adults and children with moderate-to-severe asthma.

Neil C ThomsonPubMed ↗Publisher ↗

No numbers read from the abstract.